Pharmaceutical Sector in the New Reimbursement Era

Management
doi 10.2478/v10286-012-0015-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Assessing Efficiency in the Pharmaceutical Sector of Nigeria

Central Bank of Nigeria Journal of Applied Statistics
2019English

PHP40 Equity in Pharmaceutical Pricing and Reimbursement: Crossing the Income Divide in Asia Pacific

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

The Impact of the Economic Recession and Pharmaceutical-Health Service Agreement on the Probability and Time of Reimbursement of New Medicines in Ireland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

A Need for the Standardization of the Pharmaceutical Sector in Libya

Libyan Journal of Medicine
Medicine
2010English

The Effect of the Marketing Strategy in Performance of the Pharmaceutical Sector

Socio-Economic Perspectives on Consumer Engagement and Buying Behavior
English

Developing Synergies in the Pharmaceutical Sector: M&A Activity Post 2005

International Journal of Recent Technology and Engineering
EngineeringManagement of TechnologyInnovation
2019English

International Best Practices for Negotiating 'Reimbursement Contracts' With Price Rebates From Pharmaceutical Companies

Health Affairs
MedicineHealth Policy
2013English

Study of Factors Affecting on the Development of the Pharmaceutical Sector Enterprises

ScienceRise: Pharmaceutical Science
2019English

The New Era of Neuromodulation

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy